Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,084 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Temporal Dynamics of Cardiovascular Risk in Patients with Chronic Obstructive Pulmonary Disease During Stable Disease and Exacerbations: Review of the Mechanisms and Implications.
Simons SO, Heptinstall AB, Marjenberg Z, Marshall J, Mullerova H, Rogliani P, Nordon C, Hawkins NM. Simons SO, et al. Among authors: marshall j. Int J Chron Obstruct Pulmon Dis. 2024 Oct 10;19:2259-2271. doi: 10.2147/COPD.S466280. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 39411574 Free PMC article. Review.
Budesonide/Glycopyrrolate/Formoterol for the Management of COPD in a UK Primary Care Population: Real-World Use and Early Medication Success.
Müllerová H, Chan JSK, Heatley H, Carter V, Townend J, Skinner D, Franzén S, Marshall J, Price D. Müllerová H, et al. Among authors: marshall j. Int J Chron Obstruct Pulmon Dis. 2024 May 24;19:1153-1166. doi: 10.2147/COPD.S452624. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 38813078 Free PMC article.
Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT.
Stolz D, Hermansson E, Ouwens M, Singh B, Sharma A, Jackson D, Darken P, Marshall J, Bowen K, Müllerová H, Alcázar Navarrete B, Russell R, Han MK, Tansey-Dwyer D. Stolz D, et al. Among authors: marshall j. Curr Med Res Opin. 2023 Oct;39(10):1395-1405. doi: 10.1080/03007995.2023.2247969. Epub 2023 Aug 29. Curr Med Res Opin. 2023. PMID: 37583267 Free article.
The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study.
Jones R, Martin J, Thomas V, Skinner D, Marshall J, Stagno d'Alcontres M, Price D. Jones R, et al. Among authors: marshall j. Int J Chron Obstruct Pulmon Dis. 2017 Aug 17;12:2445-2454. doi: 10.2147/COPD.S141409. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28860739 Free PMC article.
7,084 results